Effects of lithium on peripheral neuropathy induced by vincristine in rats

Acta Medica Iranica

Volumn 50, Issue 6, 2012, Pages 373-379

  Alimoradi, Houman ^a   Pourmohammadi, Nasir ^b   Mehr, Shahram Ejtemaei ^b   Hassanzadeh, Gholamreza ^c   Hadian, Mohammad Reza ^d   Sharifzadeh, Mohammad ^c   Bakhtiarian, Azam ^b   Dehpour, Ahmad Reza ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lithium chloride; Peripheral neuropathy; Rat; Vincristine

Indexed keywords

LITHIUM CHLORIDE; VINCRISTINE;

ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; BODY WEIGHT; CACHEXIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; EDEMA; ERYTHROCYTE LITHIUM CONCENTRATION; HISTOLOGY; HYPOALGESIA; LOOSE FECES; MALE; MORTALITY; MOTOR NERVE; NERVE CONDUCTION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PERIPHERAL NEUROPATHY; PLASMA LITHIUM CONCENTRATION; RAT; SENSORIMOTOR NEUROPATHY; SENSORY NERVE; STEADY STATE; SURVIVAL; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; LITHIUM CHLORIDE; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; VINCRISTINE;

EID: 84865698317     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced nonHodgkin's lymphoma. N Engl J Med 1993;328(14):1002-6.
2. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH, Huh YO, Spinolo J, Dicke K, Barlogie B. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990;8(6):994-1004.
3. Owellen RJ, Owens AH Jr, Donigian DW. The binding of vincristine, vinblastine and colchicine to tubulin. Biochem Biophys Res Commun 1972;47(4):685-91.
4. Rosenthal S, Kaufman S. Vincristine neurotoxicity. Ann Intern Med 1974;80(6):733-7.
5. Chuang DM, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, Kanai H, Hough C, Hiroi T, Leeds P. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002;4(2):129-36.
6. Zhu ZF, Wang QG, Han BJ, William CP. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res Bull 2010;83(5):272-7.
7. Pourmohammadi N, Alimoradi H, Mehr SE, Hassanzadeh G, Hadian MR, Sharifzadeh M, Bakhtiarian A, Dehpour AR. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats. Basic Clin Pharmacol Toxicol 2012;110(3):231-7.
8. Petrini M, Vaglini F, Cervetti G, Cavalletti M, Sartucci F, Murri L, Corsini GU. Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication. J Neural Transm 1999;106(5-6):569-75.
9. Dashti-Khavidaki S, Ahmadi-Abhari SA, Ghaeli P, Farsam H, Dehpour AR, Mandavi-Mazdeh M, Hatmi ZN, Fahimi F. Relationship between erythrocyte lithium concentration and renal concentrating capacity. J Clin Pharm Ther 2003;28(6):451-6.
10. Aloe L, Manni L, Properzi F, De Santis S, Fiore M. Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton Neurosci 2000;86(1-2):84-93.
11. Jadavji NM, Kolb B, Metz GA. Enriched environment improves motor function in intact and unilateral dopaminedepleted rats. Neuroscience 2006;140(4):1127-38.
12. Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, Davies M, Hasnie F, Hall S, McMahon SB, Rice AS. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp 120 induced painful neuropathy. Pain 2007;133(1-3):47-63.
13. Ja'afer FM, Hamdan FB, Mohammed FH. Vincristineinduced neuropathy in rat: electrophysiological and histological study. Exp Brain Res 2006;173(2):334-45.
14. Rahimi Balaei M, Momeny M, Babaeikelishomi R, Ejtemaei Mehr S, Tavangar SM, Dehpour AR. The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat. Eur J Pharmacol 2010;641(2-3):193-8.
15. Bhattacharyya B, Wolff J. Stabilization of microtubules by lithium ion. Biochem Biophys Res Commun 1976;73(2):383-90.
16. Burstein DE, Seeley PJ, Greene LA. Lithium ion inhibits nerve growth factor-induced neurite outgrowth and phosphorylation of nerve growth factor-modulated microtubule-associated proteins. J Cell Biol 1985;101(3):862-70.
17. Goold RG, Owen R, Gordon-Weeks PR. Glycogen synthase kinase 3beta phosphorylation of microtubuleassociated protein 1B regulates the stability of microtubules in growth cones. J Cell Sci 1999;112 (Pt 19):3373-84.
18. Hong M, Chen DC, Klein PS, Lee VM. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997;272(40):25326-32.
19. Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999;274(10):6039-42.
20. Xu J, Culman J, Blume A, Brecht S, Gohlke P. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003;34(5):1287-92.